Baillie Gifford & CO Penumbra Inc Transaction History
Baillie Gifford & CO
- $128 Billion
- Q3 2025
A detailed history of Baillie Gifford & CO transactions in Penumbra Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 908,546 shares of PEN stock, worth $253 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
908,546
Previous 922,127
1.47%
Holding current value
$253 Million
Previous $237 Million
2.74%
% of portfolio
0.18%
Previous 0.19%
Shares
33 transactions
Others Institutions Holding PEN
# of Institutions
472Shares Held
30.7MCall Options Held
309KPut Options Held
95.9K-
Black Rock Inc. New York, NY4.26MShares$1.19 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.84MShares$1.07 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.79MShares$500 Million0.05% of portfolio
-
State Street Corp Boston, MA1.16MShares$324 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il971KShares$270 Million0.04% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $10.6B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...